Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.22-
QQQ
716.08-
BTC/USD
79145.510.8826%
DIA
525.77-
GLD
406.10-
TLT
82.19-

SNDL Inc

SNDLNASDAQ
Trade with Public
Trade with Public
$1.45
0.010.69%
Last update: Sep 9, 9:27 AM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareOptionsStock Report

SNDL Analyst Price Targets

Wall Street analyst price targets and consensus rating for SNDL (SNDL).

Price Target Range — 2 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$4Upside to Avg. PT+184.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 3, 2025Alliance Global PartnersAaron GreyInitiateBuy$5
Jul 17, 2024Canaccord GenuityYewon KangAssumesSpeculative Buy$3

Analyst Ratings News

PRO
Alliance Global Partners Initiates Coverage On SNDL with Buy Rating, Announces Price Target of $5

Alliance Global Partners analyst Aaron Grey initiates coverage on SNDL (NASDAQ:SNDL) with a Buy rating and announces Price Target of $5.
Benzinga Newsdesk

M&A Frenzy And Deflation Post-Election: Which Companies Are Ready To Win Big In Florida's Cannabis Market

November's election could bring significant growth opportunities—or intensified competition for cannabis companies in the Florida market.
Nicolás Jose Rodriguez

PRO
Canaccord Genuity Assumes SNDL at Speculative Buy, Announces Price Target of $3.25

Canaccord Genuity analyst Yewon Kang assumes SNDL (NASDAQ:SNDL) with a Speculative Buy rating and announces Price Target of $3.25.
Benzinga Newsdesk

Chicago Atlantic Real Estate Finance's Stock Valuation & Dividend Yield Are Leaving Competitors Behind

Chicago Atlantic Real Estate Finance (NASDAQ: REFI) stands out in the cannabis capital providers and mortgage REIT (mREIT) sectors due to its premium valuation, impressive dividend yield, and robust growth track record.
Nicolás Jose Rodriguez

Aurora Cannabis Shoots For $512M Market: Marijuana Stock Analyst Initiates Coverage With Neutral

Aurora Cannabis (NASDAQ: ACB), a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo Zuanic, a seasoned marijuana stock analyst from Zuanic & Associates, has initiated coverage on stock with a neutral rating.
Nicolás Jose Rodriguez

Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going

In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable shifts in sales dynamics among leading licensed producers (LPs).
Nicolás Jose Rodriguez

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved